BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Net deposit increase | 561.39%30.07B | 105.66%28.24B | 157.90%20.58B | 19,276.94%17.34B | 421.04%4.55B | -73.33%13.73B | -72.84%7.98B | -99.61%89.5M | 16,201.29%872.45M | 137.50%51.49B |
Net increase in borrowings from central bank | --5.25B | ---- | ---- | ---- | ---- | 187.79%17.11B | 383.63%15.75B | 190.88%8.67B | 401.14%5.66B | --5.95B |
Cash received from interests, fees and commissions | 12.52%4.37B | 1.46%16.83B | 3.18%12.7B | 4.41%8.21B | 1.50%3.88B | 15.59%16.59B | 11.86%12.31B | 10.12%7.87B | 14.24%3.83B | -4.98%14.35B |
Net increase in repurchase business capital | ---- | --230M | --2.93B | --12.1B | --14.9B | ---- | ---- | ---- | ---- | --4.16B |
Net increase in funds disbursed | ---- | --398.41M | ---- | ---- | --272.59M | ---- | ---- | --51.87M | ---- | --640.49M |
Cash received relating to other operating activities | -99.76%1.27M | 6,030.56%1.4B | -52.75%3.24M | -6.75%2.09M | 128,179.90%536.21M | 38.55%22.89M | -46.23%6.86M | -80.73%2.24M | -87.54%418K | 121.66%16.52M |
Cash inflows from operating activities | 53.95%41.03B | -1.76%49.47B | -0.86%37.47B | 103.43%38.69B | 150.47%26.65B | -34.38%50.36B | -14.07%37.8B | -43.71%19.02B | 9.18%10.64B | 87.19%76.74B |
Staff behalf paid | 5.89%378.1M | -6.14%1.08B | -4.49%829.48M | 6.95%587.02M | 10.96%357.08M | 9.41%1.15B | 12.83%868.47M | 3.71%548.85M | 59.58%321.8M | 4.94%1.05B |
All taxes paid | 21.42%286.43M | -11.63%914.55M | -15.58%670.39M | -6.88%470.49M | 2.86%235.89M | -20.52%1.03B | -21.46%794.11M | -31.14%505.24M | -33.08%229.34M | -18.26%1.3B |
Net loan and advance increase | 119.03%30.5B | 146.43%35.31B | 119.60%17.8B | 25.79%12.18B | 104.81%13.92B | 35.54%14.33B | 0.91%8.11B | 40.47%9.69B | 121.24%6.8B | -8.64%10.57B |
Net deposit in central bank and institutions | 998.26%426.47M | 94.61%1.01B | 4,370.22%687.92M | --515.5M | -69.26%38.83M | -49.74%521.05M | -97.56%15.39M | ---- | -55.19%126.31M | 518.45%1.04B |
Net lend capital | ---- | -69.50%970M | -41.57%1.04B | ---- | ---- | 218.15%3.18B | 78.09%1.78B | -51.98%480M | --1.08B | --999.51M |
Cash paid for fees and commissions | 4.87%2.43B | 37.01%9.44B | 42.05%6.95B | 43.62%4.79B | 58.41%2.31B | 29.93%6.89B | 27.44%4.89B | 29.69%3.33B | 29.81%1.46B | 9.01%5.31B |
Net increase in financial assets held for trading purposes | --1.52B | 467.29%1.88B | 25.28%2.44B | 35.33%1.73B | ---- | -91.41%331.18M | --1.95B | --1.28B | 616.09%1.04B | 66.37%3.85B |
Cash paid relating to other operating activities | 1,111.28%1.83B | -27.28%734.32M | 22.03%582.79M | 6.16%340.5M | -4.61%150.87M | 86.65%1.01B | -25.36%477.58M | 24.78%320.73M | -47.74%158.17M | -36.80%540.99M |
Cash outflows from operating activities | 1.38%38.02B | 60.27%60.95B | 63.80%43.33B | 115.24%42.72B | 153.86%37.51B | 54.23%38.03B | 40.94%26.46B | 56.00%19.85B | 70.90%14.77B | -9.33%24.66B |
Net cash flows from operating activities | 127.72%3.01B | -193.13%-11.48B | -151.68%-5.86B | -386.37%-4.03B | -162.59%-10.85B | -76.33%12.33B | -55.02%11.34B | -103.93%-828.37M | -475.01%-4.13B | 277.38%52.08B |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 60.71%13.67B | -36.46%41.13B | -37.42%29.37B | -29.16%21.78B | -33.32%8.51B | 75.57%64.73B | 138.75%46.94B | 80.34%30.74B | 9.73%12.76B | -6.15%36.87B |
Cash received from returns on investments | 1.67%72.04M | 45.36%1.33B | -0.50%557.58M | -9.44%376.39M | -57.30%70.86M | 38.48%917.96M | 65.73%560.36M | 43.50%415.64M | 110.57%165.95M | 62.12%662.9M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -96.02%286K | 184.48%8.87M | 2,692.28%8.68M | -54.36%225K | 5,694.35%7.19M | 1,025.99%3.12M | 101.95%311K | 971.74%493K | 359.26%124K | -96.17%277K |
Special items of investing cash inflows | ---- | -0.37%4.62M | ---- | ---- | ---- | -27.50%4.64M | ---- | ---- | ---- | 207.69%6.4M |
Cash inflows from investing activities | 60.09%13.74B | -35.30%42.48B | -36.97%29.94B | -28.90%22.15B | -33.57%8.58B | 74.90%65.65B | 137.51%47.5B | 79.73%31.16B | 10.41%12.92B | -5.45%37.54B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -96.90%576K | 15.40%56.69M | 50.27%41.12M | 31.38%22.73M | 194.04%18.59M | 22.22%49.13M | 0.19%27.37M | 35.94%17.3M | 168.26%6.32M | -36.70%40.2M |
Cash paid to acquire investments | 17.51%9.96B | -11.86%54.44B | -33.85%30.64B | -21.24%23.89B | -43.97%8.47B | -27.42%61.77B | 31.23%46.33B | 41.42%30.33B | 147.74%15.12B | 28.98%85.11B |
Cash outflows from investing activities | 17.26%9.96B | -11.84%54.5B | -33.80%30.68B | -21.21%23.91B | -43.87%8.49B | -27.40%61.82B | 31.20%46.35B | 41.42%30.34B | 147.75%15.13B | 28.92%85.15B |
Net cash flows from investing activities | 3,990.96%3.79B | -413.54%-12.02B | -164.99%-745.49M | -315.92%-1.76B | 104.20%92.53M | 108.05%3.83B | 107.48%1.15B | 119.73%812.92M | -139.39%-2.21B | -80.70%-47.61B |
Financing cash flow | ||||||||||
Cash from bonds issue | -6.63%24.46B | 31.86%116.66B | 17.41%76.46B | -8.06%47.34B | 11.92%26.19B | 22.63%88.47B | 85.61%65.12B | 296.12%51.5B | 1,070.23%23.4B | -9.02%72.15B |
Cash inflows from financing activities | -6.63%24.46B | 31.86%116.66B | 17.41%76.46B | -8.06%47.34B | 11.92%26.19B | 22.63%88.47B | 85.61%65.12B | 296.12%51.5B | 1,070.23%23.4B | -9.02%72.15B |
Borrowing repayment | -3.05%18.43B | 4.73%95.06B | 11.72%74.85B | 2.70%44.94B | 5.20%19.01B | 15.78%90.77B | 33.81%67B | 32.97%43.76B | 55.51%18.07B | 31.21%78.4B |
Dividend interest payment | -0.67%76.28M | -57.66%376.99M | -57.71%376.48M | -78.73%163.87M | 1.49%76.8M | -17.09%890.5M | -11.21%890.28M | -10.97%770.39M | 35,096.28%75.67M | -63.23%1.07B |
Cash payments relating to other financing activities | ---- | ---- | -3.31%97.06M | -10.09%61.46M | ---- | ---- | -2.41%100.38M | 9.83%68.36M | -32.97%23.69M | 1.05%137.64M |
Special items of financing cash outflows | 13.15%30.37M | -3.73%128.61M | ---- | ---- | --26.84M | --133.59M | ---- | ---- | ---- | ---- |
Cash outflows from financing activities | -3.02%18.54B | 4.11%95.57B | 10.79%75.32B | 1.27%45.17B | 5.20%19.11B | 15.30%91.79B | 32.86%67.99B | 31.80%44.6B | 55.89%18.17B | 26.76%79.61B |
Net cash flows from financing activities | -16.37%5.92B | 734.75%21.09B | 139.42%1.13B | -68.40%2.18B | 35.24%7.08B | 55.48%-3.32B | 82.14%-2.87B | 133.11%6.9B | 154.22%5.24B | -145.26%-7.46B |
Net cash flow | ||||||||||
Net increase in cash and cash equivalents | 445.50%12.71B | -118.77%-2.41B | -156.93%-5.47B | -152.37%-3.6B | -233.74%-3.68B | 528.92%12.84B | 254.89%9.62B | 276.84%6.88B | 62.70%-1.1B | -175.84%-2.99B |
Add:Begin period cash and cash equivalents | -7.86%28.25B | 72.05%30.66B | 72.05%30.66B | 72.05%30.66B | 72.05%30.66B | -14.38%17.82B | -14.38%17.82B | -14.38%17.82B | -14.38%17.82B | 23.40%20.81B |
End period cash equivalent | 51.85%40.96B | -7.86%28.25B | -8.21%25.18B | 9.51%27.05B | 61.38%26.98B | 72.05%30.66B | 87.85%27.43B | 46.00%24.7B | -6.38%16.72B | -14.38%17.82B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.